XNAS · Laboratory Analytical Instruments · S&P 500
$2.03
-$0.03 (-1.46%) today
Open $2.06 High $2.06 Low $2.03 Vol 31K Avg $2.04
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| LMRI | Lumexa Imaging Holdings, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| AMS | American Shared Hospital Services | XASE | USD | SERVICES-MEDICAL LABORATORIES |
| SERA | Sera Prognostics, Inc. Class A Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| ADVB | Advanced Biomed Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| ACON | Aclarion, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| XGN | Exagen Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
52-week price range
Price is 0.0% above its 52-week low and 0.0% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.